healthy subject
Conditions
Interventions
placebo food (code name
C-001) single ingestion group 1 placebo food - test food 1 - test food 2
placebo food (code name
C-001) single ingestion group 2 placebo food - test food 2 - test food 1
test food 1 (code name
A-001) single ingestion group 3 test food 1 - placebo food - test food 2
test food 1 (code name
A-001) single ingestion group 4 test food 1 - test food 2 - placebo food
test food 2 (code name
A-002) single ingestion group 5 test food 2 - placebo food - test food 1
test food 2 (code name
A-002) single ingestion group 5 test food 2 - test food 1 - placebo food
Sponsors
TES Holdings Co. Ltd
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1, Fasting triglyceride >=120, and < 200mg/dL 2, Aged between 35 and 64 3, BMI >= 23 and <30 kg/m2 4, Person who provides informed consent by a document
Exclusion criteria
Exclusion criteria: 1, Person who is difficult to participate the study due to dysfunctions of liver, kidney, heart, respiration, endocrine secretion, metabolism, nervous system, consciousness or diabetes, or the other dysfunctions. 2, Person who takes medication for glucose or fat metabolism, or hypertension. 3, Person who was given surgery for a disease or an injury 2 months prior to the study. 4, Individual intakes supplements or the food for specific use of health authorized the government. 5, Person had allergy against any constituents in the test diet. 6, Person who is used to take test food. 7, Individual experienced unpleasant feeling during blood drawing. 8, Person who donated 200mL or more of blood within a month prior to the study. 9, Heavy smoker 10, Person who don't record of meal recoding for 9 days 11, Shift worker 12, Person who is planned long term business trip or travel of a domestic or foreign country in study period 13, Person who can't accept to be accessed their medical records. 14, Person who have participated in other clinical studies. 15, Person who are expecting pregnancy or lactation period. 16, Person who are considered inappropriate by medical doctors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| postprandial triglyceride (blood collection : fasting and 2,3,4,6 hours after the test meal) | — |
Secondary
| Measure | Time frame |
|---|---|
| apo-B48 physical examination blood general analysis biochemical test urinalysis | — |
Countries
Japan
Contacts
Public ContactRyoma Ryoma
TES Holdings Co. Ltd Sales department for tissue engineering and clinical research
Outcome results
None listed